Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

Oncogene

Volumn 22, Issue 27, 2003, Pages 4150-4165

  Song, Lanxi ^a,b   Turkson, James ^a,b   Karras, James G ^c   Jove, Richard ^a,b   Haura, Eric B ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

EGF receptor; HGF; IL 6; Lung cancer; Src; STAT proteins; Tyrosine kinase inhibitors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; PROTEIN SRC; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL NUCLEUS; CELL SURVIVAL; CYTOKINES; DNA; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; G2 PHASE; GENES, DOMINANT; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037699512     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206479     Document Type: Article

References (90)

1. Ankrapp DP and Bevan DR. (1993). Cancer Res., 53, 3399-3404.
2. Antoniades HN, Galanopoulos T, Neville-Golden J and O'Hara CJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 3942-3946.
3. Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP and Roth M. (1998). Am. J. Respir. Cell Mol. Biol., 19, 606-612.
4. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L and Courtneidge SA. (2000). Mol. Cell Biol., 20, 9018-9027.
5. Bowman T, Garcia R, Turkson J and Jove R. (2000). Oncogene, 19, 2474-2488.
6. Bowman T and Jove R. (1999). Cancer Control, 6, 615-619.
7. Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Holscher AH and Danenberg PV. (2001). Clin. Cancer Res., 7, 1850-1855.
8. Brognard J, Clark AS, Ni Y and Dennis PA. (2001). Cancer Res., 61, 3986-3997.
9. Bromberg J and Darnell Jr JE. (2000). Oncogene, 19, 2468-2473.
10. Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell JE. (1998). Mol. Cell Biol., 18, 2553-2558.
11. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE. (1999). Cell, 98, 295-303.
12. Budde RJ, Ke S and Levin VA. (1994). Cancer Biochem. Biophys., 14, 171-175.
13. Carbone DP. (1997). Semin. Oncol., 24, 388-401.
14. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R. (1999). Immunity, 10, 105-115.
15. Chaturvedi P, Reddy MV and Reddy EP. (1998). Oncogene, 16, 1749-1758.
16. Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR and Tortora G. (2000). Clin. Cancer Res., 6, 2053-2063.
17. Darnell Jr JE (1997). Science, 277, 1630-1635.
18. DeGregori J, Kowalik T and Nevins JR. (1995). Mol. Cell. Biol., 15, 4215-4224.
19. Doucet C, Jasmin C and Azzarone B. (2000). Oncogene, 19, 5898-5905.
20. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R and Loughran Jr TP. (2001a). J. Clin. Invest., 107, 351-362.
21. Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran Jr TP and Wei S. (2001b). J. Immunol., 166, 7486-7495.
22. Fang K and Chen MH. (1999). Int. J. Cancer, 81, 471-478.
23. Favoni RE, de Cupis A, Ravera F, Cantoni C, Pirani P, Ardizzoni A, Noonan D and Biassoni R. (1994). Int. J. Cancer, 56, 858-866.
24. Fernandes A, Hamburger AW and Gerwin BI. (1999). Int. J. Cancer, 83, 564-570.
25. Fry DW. (1999). Pharmacol. Ther., 82, 207-218.
26. Fumagalli S, Totty NF, Hsuan JJ and Courtneidge SA. (1994). Nature, 368, 871-874.
27. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R. (2001). Oncogene, 20, 2499-2513.
28. Garcia R and Jove R. (1998). J. Biomed. Sci., 5, 79-85.
29. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP and Jove R. (1997). Cell Growth Differ., 8, 1267-1276.
30. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ. (1998). J. Clin. Invest., 102, 1385-1392.
31. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y and Kim JD. (2000a). Proc. Natl. Acad. Sci. USA, 97, 4227-4232.
32. Grandis JR, Zeng Q and Drenning SD. (2000b). Laryngoscope, 110, 868-874.
33. Greenlee RT, Murray T, Bolden S and Wingo PA. (2000). CA Cancer J. Clin., 50, 7-33.
34. Hallek M, Neumann C, Schaffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD and Emmerich B. (1997). Exp. Hematol., 25, 1367-1377.
35. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
36. Hitt DC, Booth JL, Dandapani V, Pennington LR, Gimble JM and Metcalf J. (2000). Mol. Biotechnol., 14, 197-203.
37. Horvath CM, Wen Z and Darnell Jr JE. (1995). Genes Dev., 9, 984-994.
38. Hung W and Elliott B. (2001). J. Biol. Chem., 276, 12395-12403.
39. Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N and Hirano T. (1998). J. Biol. Chem., 273, 6132-6138.
40. Ichimura E, Maeshima A, Nakajima T and Nakamura T. (1996). Jpn. J. Cancer Res., 87, 1063-1069.
41. Irby RB and Yeatman TJ. (2000). Oncogene, 19, 5636-5642.
42. Jiang Y, Rom WN, Yie TA, Chi CX and Tchou-Wong KM. (1999). Oncogene, 18, 6071-6077.
43. Jove R and Hanafusa H. (1987). Annu. Rev. Cell Biol., 3, 31-56.
44. Kawai T, Hiroi S and Torikata C. (1997). Lab. Invest., 77, 431-436.
45. Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M and Hirano T. (1999). J. Exp. Med., 189, 63-73.
46. Kopantzev Y, Heller M, Swaminathan N and Rudikoff S. (2002). Oncogene, 21, 6791-6800.
47. Kraker AJ, Hartl BG, Amar AM, Barvian MR, Showalter HD and Moore CW. (2000). Biochem. Pharmacol., 60, 885-898.
48. Krystal GW, DeBerry CS, Linnekin D and Litz J. (1998). Cancer Res., 58, 4660-4666.
49. Krystal GW, Honsawek S, Litz J and Buchdunger E. (2000). Clin. Cancer Res., 6, 3319-3326.
50. Lee M, Draoui M, Zia F, Gazdar A, Oie H, Bepler G, Bellot F, Tarr C, Kris R and Moody TW. (1992). J. Natl. Cancer Inst. Monogr., 13, 117-123.
51. Lei W, Mayotte JE and Levitt ML. (1998). Biochem. Biophys. Res. Commun., 245, 939-945.
52. Lei W, Mayotte JE and Levitt ML. (1999). Anticancer Res., 19, 221-228.
53. Levitzki A. (1999). Pharmacol. Ther., 82, 231-239.
54. Ling YH, Zou Y and Perez-Soler R. (2000). Anticancer Res., 20, 693-702.
55. Liu J and Kern JA. (2002). Am. J. Respir. Cell Mol. Biol., 27, 306-313.
56. Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito MJ and Oramas J. (1999). Cytokine, 11, 80-86.
57. Mazurenko NN, Kogan EA, Zborovskaya IB and Kisseljov FL. (1992). Eur. J. Cancer, 28, 372-377.
58. Moasser MM, Srethapakdi M, Sachar KS, Kraker AJ and Rosen N. (1999). Cancer Res., 59, 6145-6152.
59. Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, Guinosso CJ, Kawasaki AM, Cook PD and Freier SM. (1993). J. Biol. Chem., 268, 14514-14522.
60. Nevins JR, DeGregori J, Jakoi L and Leone G. (1997). Methods Enzymol., 283, 205-219.
61. Non-small cell lung cancer collaborative group (1995). BMJ, 311, 899-909.
62. Norman P. (2001). Curr. Opin. Invest. Drugs, 2, 428-434.
63. Odajima J, Matsumura I, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T and Kanakura Y. (2000). J. Biol. Chem. 275, 24096-24105.
64. Olayioye MA, Beuvink I, Horsch K, Daly JM and Hynes NE. (1999). J. Biol. Chem., 274, 17209-17218.
65. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM and Di Renzo MF. (1996). Br. J. Cancer, 74, 1862-1868.
66. Rabiasz GJ, Langdon SP, Bartlett JM, Crew AJ, Miller EP, Scott WN, Smyth JF and Miller WR. (1992). Br. J. Cancer, 66, 254-259.
67. Rahimi N, Hung W, Tremblay E, Saulnier R and Elliott B. (1998). J. Biol. Chem., 273, 33714-33721.
68. Reddy EP, Korapati A, Chaturvedi P and Rane S. (2000). Oncogene, 19, 2532-2547.
69. Roche S, Fumagalli S and Courtneidge SA. (1995). Science, 269, 1567-1569.
70. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J and Dmitrovsky E. (1993). Cancer Res., 53, 2379-2385.
71. Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J and Dmitrovsky E. (1997). Clin. Cancer Res., 3, 515-522.
72. Schaeffer M, Schneiderbauer M, Weidler S, Tavares R, Warmuth M, de Vos G and Hallek M. (2001). Mol. Cell. Biol., 21, 8068-8081.
73. Shen Y, Devgan G, Darnell JE and Bromberg JF. (2001). Proc. Natl. Acad. Sci. USA, 98, 1543-1548.
74. Siegfried JM, Weissfeld LA, Luketich JD, Weyant RJ, Gubish CT and Landreneau RJ. (1998). Ann. Thorac. Surg., 66, 1915-1918.
75. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR and Landreneau RJ. (1997). Cancer Res., 57, 433-439.
76. Sirotnak FM, Zakowski MF, Miller VA, Scher HI and Kris MG. (2000). Clin. Cancer Res., 6, 4885-4892.
77. Song JI and Grandis JR. (2000). Oncogene, 19, 2489-2495.
78. Takahashi T, Fukuda K, Pan J, Kodama H, Sano M, Makino S, Kato T, Manabe T and Ogawa S. (1999). Circ Res., 85, 884-891.
79. Takanami I, Imamura T, Yamamoto Y and Kodaira S. (1995). J. Surg. Oncol., 58, 40-43.
80. Taylor SJ and Shalloway D. (1994). Nature, 368, 867-871.
81. Tice DA, Biscardi JS, Nickles AL and Parsons SJ. (1999). Proc. Natl. Acad. Sci. USA, 96, 1415-1420.
82. Tsao MS, Liu N, Chen JR, Pappas J, Ho J, To C, Viallet J, Park M and Zhu H. (1998). Lung Cancer, 20, 1-16.
83. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R. (1998). Mol. Cell Biol., 18, 2545-2552.
84. Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE and Salgia R. (2000a). Oncogene, 19, 3521-3528.
85. Wang YZ, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ. (2000b). Oncogene, 19, 2075-2085.
86. Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T and Ogura T. (1995). Br. J. Cancer, 71, 1095-1098.
87. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R. (1995). Science, 269, 81-83.
88. Zhang YW, Wang LM, Jove R and Vande Woude GF. (2002). Oncogene, 21, 217-226.
89. Zhong Z, Wen Z and Darnell Jr JE. (1994). Science, 264, 95-98.
90. Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB and Wang LH. (2000). J. Biol. Chem., 275, 15099-15105.